MAM
ATYR

Marquette Asset Management’s aTyr Pharma ATYR Stock Holding History

Marquette Asset Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-18,848
Closed -$61K – 243
2020
Q3 		$61K Hold
18,848
– – 0.02% 129
2020
Q2 		$84K Hold
18,848
– – 0.03% 124
2020
Q1 		$53K Buy
+18,848
New +$81.4K 0.02% 146

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Marquette Asset Management's ATYR Position: Q4 2020 in Review

Marquette Asset Management sold out of aTyr Pharma (ATYR) in Q4 2020, closing a stake of 18,848 shares — an estimated $61K sold.

Marquette Asset Management first reported a position in ATYR in Q1 2020 and held it in 3 quarters. The position peaked at $84K in Q2 2020. 23 funds tracked by Wall St. Rank hold ATYR as of Q4 2020.

  • Marquette Asset Management reported no remaining aTyr Pharma position as of Q4 2020 after selling out during the quarter.
  • Marquette Asset Management sold 18,848 aTyr Pharma shares in Q4 2020, an estimated $61K.
  • Marquette Asset Management first reported a position in aTyr Pharma in Q1 2020 and held it in 3 quarters.
  • Marquette Asset Management's aTyr Pharma position peaked at $84K in Q2 2020.
  • 23 funds tracked by Wall St. Rank held aTyr Pharma as of Q4 2020.

Based on Marquette Asset Management's 13F filing for Q4 2020, filed 15 Jan 2021.